Study design of ASPirin in Reducing Events in the Elderly (ASPREE): A randomized, controlled trial
- 1 November 2013
- journal article
- research article
- Published by Elsevier BV in Contemporary Clinical Trials
- Vol. 36 (2), 555-564
- https://doi.org/10.1016/j.cct.2013.09.014
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trialsThe Lancet, 2011
- Effects of a Physical Activity Intervention on Measures of Physical Performance: Results of the Lifestyle Interventions and Independence for Elders Pilot (LIFE-P) StudyThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2006
- ADCS Prevention Instrument Project: Assessment of Instrumental Activities of Daily Living for Community-dwelling Elderly Individuals in Dementia Prevention Clinical TrialsAlzheimer Disease & Associated Disorders, 2006
- The reliability of cluster and switch scores for the controlled oral word association testArchives of Clinical Neuropsychology, 2003
- Rationale for a Trial of Low-Dose Aspirin for the Primary Prevention of Major Adverse Cardiovascular Events and Vascular Dementia in the ElderlyDrugs & Aging, 2003
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ, 2002
- A 12-Item Short-Form Health SurveyMedical Care, 1996
- Final Report on the Aspirin Component of the Ongoing Physicians' Health StudyThe New England Journal of Medicine, 1989
- Randomised trial of prophylactic daily aspirin in British male doctorsBMJ, 1988
- The CES-D ScaleApplied Psychological Measurement, 1977